aiv001
Small moleculeexperimental
Clinical trial activity
4 trials · 3 clinical orgs · 0 marketing orgs
Phase 1
4
Phase 2
3
Phase 3
0
Phase 4
0
Earliest trial started Sep 30, 2018 (NCT03639883)
Timeline
2010s
- Jan 1, 2018
Earliest Phase 1 Sponsor(trial)
Indications
Studied for
Mechanism of action
- UnclearUnclear
Unclear unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04827875 | Phase 1 | May 31, 2021 | Aiviva BioPharma Inc. |
| NCT04470726 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2020 | Aiviva BioPharma Inc. |
| NCT03883945 | Phase 1/Phase 2 (Phase 2) | Aug 31, 2019 | Aiviva BioPharma Inc., Cosmetic Laser Dermatology |
| NCT03639883 | Phase 1/Phase 2 (Phase 2) | Sep 30, 2018 | Aiviva BioPharma Inc., Novella Clinical |
Showing 4 of 4 trials
Page 1 / 1
Organizations
Research & Development (3)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Aiviva BioPharma Inc. | For profit | 4 | 4 | 2 | 2018 |
| Cosmetic Laser Dermatology | Academic/Hospital | 1 | 0 | 1 | 2019 |
| Novella Clinical | For profit | 1 | 0 | 1 | 2018 |
3 organizations
Page 1 / 1